- Home
- RLYB vs TACT Comparison
RLYB vs TACT Comparison
Compare RLYB & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- TACT
- Stock Information
- Founded
- RLYB 2018
- TACT 1996
- Country
- RLYB United States
- TACT United States
- Employees
- RLYB N/A
- TACT N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- RLYB Health Care
- TACT Technology
- Exchange
- RLYB Nasdaq
- TACT Nasdaq
- Market Cap
- RLYB 45.2M
- TACT 40.6M
- IPO Year
- RLYB 2021
- TACT 1996
- Fundamental
- Price
- RLYB $0.92
- TACT $4.12
- Analyst Decision
- RLYB Buy
- TACT Strong Buy
- Analyst Count
- RLYB 6
- TACT 1
- Target Price
- RLYB $8.10
- TACT $7.50
- AVG Volume (30 Days)
- RLYB 125.7K
- TACT 16.0K
- Earning Date
- RLYB 11-07-2024
- TACT 11-07-2024
- Dividend Yield
- RLYB N/A
- TACT N/A
- EPS Growth
- RLYB N/A
- TACT N/A
- EPS
- RLYB N/A
- TACT N/A
- Revenue
- RLYB $598,000.00
- TACT $46,418,000.00
- Revenue This Year
- RLYB N/A
- TACT N/A
- Revenue Next Year
- RLYB N/A
- TACT $16.86
- P/E Ratio
- RLYB N/A
- TACT N/A
- Revenue Growth
- RLYB N/A
- TACT N/A
- 52 Week Low
- RLYB $0.84
- TACT $3.32
- 52 Week High
- RLYB $3.46
- TACT $7.97
- Technical
- Relative Strength Index (RSI)
- RLYB 39.08
- TACT 51.56
- Support Level
- RLYB $0.84
- TACT $3.90
- Resistance Level
- RLYB $1.24
- TACT $4.07
- Average True Range (ATR)
- RLYB 0.08
- TACT 0.16
- MACD
- RLYB -0.02
- TACT 0.00
- Stochastic Oscillator
- RLYB 19.80
- TACT 61.43
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.